BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29998822)

  • 1. Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?
    Aloush V; Dotan I; Ablin JN; Elkayam O
    Clin Exp Rheumatol; 2019; 37(1):32-36. PubMed ID: 29998822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Aug; 16(8):1367-75. PubMed ID: 20024902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
    Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New serological biomarkers of inflammatory bowel disease.
    Li X; Conklin L; Alex P
    World J Gastroenterol; 2008 Sep; 14(33):5115-24. PubMed ID: 18777587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New serologic markers for inflammatory bowel disease diagnosis.
    Dotan I
    Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease serology in Asia and the West.
    Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
    World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-cyclic citrullinated peptide antibodies in patients with spondyloarthritis: A retrospective study.
    Yamazaki H; Kuroiwa T; Shinmura K; Yukioka M; Murata N
    Mod Rheumatol; 2021 Mar; 31(2):458-461. PubMed ID: 32340503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
    Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
    Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of anti-glycan antibodies in patients with cystic fibrosis.
    Hirche TO; Stein J; Hirche H; Hausmann J; Wagner TO; Behrens F; Schröder O
    Eur J Med Res; 2011 Sep; 16(9):385-90. PubMed ID: 22024437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.
    Sładek M; Wasilewska A; Swiat A; Cmiel A
    Prz Gastroenterol; 2014; 9(4):232-41. PubMed ID: 25276255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
    Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
    PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.
    Bonneau J; Dumestre-Perard C; Rinaudo-Gaujous M; Genin C; Sparrow M; Roblin X; Paul S
    Autoimmun Rev; 2015 Mar; 14(3):231-45. PubMed ID: 25462578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
    Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
    Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
    Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
    Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.